These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21198274)

  • 41. Serum erythropoietin measurements by a one-step sandwich enzyme linked immunosorbent assay in patients with hepatocellular carcinoma and liver cirrhosis.
    Sawabe Y; Iida S; Tabata Y; Yonemitsu H
    Jpn J Clin Oncol; 1993 Oct; 23(5):273-7. PubMed ID: 7693989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
    Tanaka Y; Kashiwagi T; Tsutsumi H; Nagasawa M; Toyama T; Ozaki S; Naito M; Ishibashi K; Azuma M
    Hepatogastroenterology; 1999; 46(28):2464-8. PubMed ID: 10522021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Talin-1; other than a potential marker for hepatocellular carcinoma diagnosis.
    Aboelfotoh AO; Foda EM; Elghandour AM; Teama NM; Abouzein RA; Mohamed GA
    Arab J Gastroenterol; 2020 Jun; 21(2):80-84. PubMed ID: 32439236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma protein biomarkers of hepatocellular carcinoma in HCV-infected alcoholic patients with cirrhosis.
    Ferrín G; Rodríguez-Perálvarez M; Aguilar-Melero P; Ranchal I; Llamoza C; Linares CI; González-Rubio S; Muntané J; Briceño J; López-Cillero P; Montero-Álvarez JL; de la Mata M
    PLoS One; 2015; 10(3):e0118527. PubMed ID: 25789864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
    Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
    Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
    Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
    Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical relevance of serum endoglin level in Egyptian hepatocellular carcinoma patients.
    Elnemr DM; Abdel-Azeez HA; Labib HA; Abo-Taleb FM
    Clin Lab; 2012; 58(9-10):1023-8. PubMed ID: 23163119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis.
    Fabris C; Pirisi M; Soardo G; Falleti E; Pezzetta F; Vitulli D; Toniutto P; Bortolotti N; Gonano F; Bartoli E
    J Cancer Res Clin Oncol; 1994; 120(4):229-32. PubMed ID: 7507117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.
    Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen C
    Hepatology; 2007 Nov; 46(5):1426-35. PubMed ID: 17683101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
    Niermeijer P; Gips CH; Marrink J; Qué GS
    Neth J Med; 1976; 19(1):15-8. PubMed ID: 55984
    [No Abstract]   [Full Text] [Related]  

  • 53. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
    Niermeijer P; Gips CH; Marrink J; QUE GS
    Neth J Med; 1976; 19(1):25-8. PubMed ID: 55985
    [No Abstract]   [Full Text] [Related]  

  • 54. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
    Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relation between sex hormones and hepatocellular carcinoma.
    El Mahdy Korah T; Abd Elfatah Badr E; Mohamed Emara M; Ahmed Samy Kohla M; Gamal Saad Michael G
    Andrologia; 2016 Nov; 48(9):948-955. PubMed ID: 26791111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.
    Giannini EG; Sammito G; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Trevisani F;
    Cancer; 2014 Jul; 120(14):2150-7. PubMed ID: 24723129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
    Collazos J
    Cancer; 1992 Sep; 70(5):1202-3. PubMed ID: 1381271
    [No Abstract]   [Full Text] [Related]  

  • 58. Serum neopterin levels in patients with hepatocellular carcinoma.
    Antoniello S; Auletta M; Magri P; Russo N
    Biol Chem Hoppe Seyler; 1992 Nov; 373(11):1165-8. PubMed ID: 1282321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma proteosome level as a potential marker for hepatocellular carcinoma.
    Salama HM; Abdel-Haleem H; Taha FM; Abdel-Azeez RA; Marzaban RN; El-Nahaas SM; Darwish T
    Arab J Gastroenterol; 2013 Sep; 14(3):87-93. PubMed ID: 24206735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
    Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
    EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.